Why Listen to Global Trial Accelerators™?
Bringing a medical device, biologic, or radiopharmaceutical from concept to first-in-human study is one of the most complex challenges in healthcare. Lengthy regulatory timelines, rising costs, and limited clinical trial sites can stall even the most promising innovations. Global Trial Accelerators™ is the clinical trials podcast built to solve that problem.
What You Will Learn
Every episode delivers practical strategies from industry leaders who have navigated the global clinical research landscape. You will hear from CRO executives, regulatory affairs directors, medtech startup founders, and healthcare investors who share the frameworks they use to accelerate device approvals and drug development. Topics range from regulatory strategy in Colombia, Mexico, and Panama to first-in-human trial design, site selection in Eastern Europe, and reimbursement pathways across Latin America.
Who This Podcast Is For
This podcast is designed for medtech and biopharma founders, regulatory affairs professionals, clinical operations managers, and healthcare investors looking for a competitive edge. Whether you are a startup preparing for your first FDA submission, a mid-stage company exploring international expansion, or an investor evaluating clinical-stage opportunities, Global Trial Accelerators™ gives you the insider knowledge you need to make faster, smarter decisions.
Frequently Asked Questions
How often are new episodes released?
New episodes are published weekly, featuring a mix of expert interviews, regulatory deep dives, and practical strategy sessions covering clinical trials in Latin America, Eastern Europe, and Australia.
Can clinical trials in Latin America really be faster and more affordable?
Yes. Many countries in Latin America offer streamlined ethics committee approvals that can be completed in four to six weeks compared to eight or more months in the United States or European Union. Combined with lower operational costs, sponsors can reduce overall trial budgets by up to thirty percent while maintaining full FDA and EMA compliance.
What types of clinical trials does this podcast cover?
The podcast covers first-in-human feasibility studies, pivotal trials, post-market surveillance, and regulatory submissions for medical devices, combination products, biologics, and radiopharmaceuticals. Episodes also explore emerging areas like theranostics, AI-driven diagnostics, and decentralized trial models.
Who are the hosts of Global Trial Accelerators™?
The podcast is hosted by Julio G. Martinez-Clark, CEO of bioaccess®, and Jesus E. Moreno, Business Development Director at bioaccess®. Together they bring over a decade of experience helping medtech and biopharma companies accelerate clinical development across more than fifteen countries.
